PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 115 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,864,000 | -38.4% | 842,478 | +34.6% | 0.01% | -44.4% |
| Q3 2016 | $41,975,000 | +134.0% | 626,024 | +4.0% | 0.01% | +125.0% |
| Q2 2016 | $17,936,000 | +164.5% | 602,071 | +160.7% | 0.00% | +100.0% |
| Q1 2016 | $6,782,000 | -64.3% | 230,920 | -4.7% | 0.00% | -50.0% |
| Q4 2015 | $19,006,000 | +10.9% | 242,424 | +6.6% | 0.00% | 0.0% |
| Q3 2015 | $17,133,000 | -35.9% | 227,353 | -0.7% | 0.00% | -33.3% |
| Q2 2015 | $26,741,000 | -82.6% | 229,042 | -64.8% | 0.01% | -83.8% |
| Q1 2015 | $153,457,000 | +34.4% | 649,940 | +7.8% | 0.04% | +32.1% |
| Q4 2014 | $114,145,000 | -10.8% | 603,082 | +12.4% | 0.03% | -22.2% |
| Q3 2014 | $127,994,000 | +266.4% | 536,506 | +1.4% | 0.04% | +260.0% |
| Q2 2014 | $34,935,000 | -42.3% | 529,311 | -9.0% | 0.01% | -44.4% |
| Q1 2014 | $60,582,000 | +7.6% | 581,739 | +7.0% | 0.02% | +5.9% |
| Q4 2013 | $56,278,000 | +84.0% | 543,593 | -4.7% | 0.02% | +70.0% |
| Q3 2013 | $30,593,000 | +36.8% | 570,135 | +13.1% | 0.01% | +25.0% |
| Q2 2013 | $22,367,000 | – | 504,098 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |